What Are the Side Effects of Canabis Oil? A Scientific Overview - Mustaf Medical
Understanding the Side Effects of Canabis Oil
Introduction
Emma wakes up each morning with a lingering knot in her neck and a restless mind after a demanding corporate job. She has tried stretching, meditation, and over‑the‑counter pain relievers with limited success. A friend suggested trying cannabis oil to alleviate her mild inflammation and improve sleep quality. Before adding any new supplement to her regimen, Emma wants to know what scientific data say about possible side effects, especially as she also takes a low‑dose antihypertensive medication. This article walks through the current evidence, focusing on the physiological mechanisms, safety considerations, and contextual comparisons of different CBD delivery forms.
Background
Side effects are unwanted physiological responses that occur at therapeutic or higher doses of a substance. Canabis oil, often marketed as a CBD‑rich extract, contains cannabidiol (CBD) along with trace amounts of other cannabinoids, terpenes, and plant lipids. The legal definition of "cannabis oil" varies by jurisdiction, but for scientific purposes it is treated as a phytocannabinoid product derived from Cannabis sativa L. Research interest has surged since the 2018 Farm Bill in the United States, prompting a wave of clinical trials and epidemiological surveys that assess both benefits and adverse events. Existing literature highlights that while many users report minimal discomfort, a subset experience measurable side effects ranging from mild gastrointestinal upset to alterations in liver enzymes.
Science and Mechanism
Absorption and Metabolism
When taken orally-as in oils, capsules, or gummies-CBD undergoes first‑pass metabolism in the liver. Bioavailability is relatively low, estimated between 6 % and 15 % for oil tinctures, though it can reach 20 %–30 % when delivered in a lipophilic matrix such as soft‑gel capsules (Hussain et al., 2022, PubMed). The lipophilic nature of CBD allows it to dissolve in dietary fats, enhancing lymphatic uptake. Once absorbed, CBD is metabolized primarily by cytochrome P450 enzymes CYP3A4 and CYP2C19, producing hydroxylated and carboxylated metabolites that are excreted via feces and urine.
Endocannabinoid Interaction
CBD exhibits low affinity for the classic cannabinoid receptors CB1 and CB2, instead acting as a negative allosteric modulator of CB1 and an indirect agonist of the endocannabinoid system. By inhibiting the enzyme fatty acid amide hydrolase (FAAH), CBD raises endogenous anandamide levels, which can influence pain perception, mood, and immune function. Additionally, CBD interacts with serotonin 5‑HT1A receptors, transient receptor potential vanilloid (TRPV) channels, and peroxisome proliferator‑activated receptors (PPARγ). These multimodal actions underpin both therapeutic potential and side‑effect profiles.
Dosage Ranges and Observed Effects
Clinical trials typically explore daily CBD doses from 5 mg to 1,500 mg. In a double‑blind, placebo‑controlled study of 120 participants with chronic anxiety, doses of 300 mg/day were associated with mild side effects in 11 % of subjects, including dry mouth, diarrhea, and somnolence (Crippa et al., 2023, NIH). Lower doses (≤50 mg/day) used for general wellness, such as in many over‑the‑counter gummies, have reported side‑effect rates below 5 %. Notably, a 2024 pharmacokinetic investigation of 30 healthy volunteers taking a 25 mg CBD gummy noted peak plasma concentrations at 2–3 hours post‑ingestion, with a half‑life of approximately 24 hours, supporting once‑daily dosing for steady exposure.
Variability Among Individuals
Genetic polymorphisms in CYP2C19 can alter CBD clearance, leading to higher systemic exposure in poor metabolizers. Age, body mass index, and concurrent food intake also modulate absorption; a high‑fat meal can double oral bioavailability compared with fasting conditions. These factors contribute to inter‑individual differences in both efficacy and adverse‑event likelihood.
Emerging Evidence on Liver Enzyme Elevation
A meta‑analysis of 14 randomized controlled trials involving over 800 participants identified a modest, statistically significant increase in alanine aminotransferase (ALT) levels at doses ≥600 mg/day (Moldzio et al., 2025, WHO). However, the clinical relevance remains uncertain, as elevations rarely exceeded two times the upper normal limit and were reversible upon discontinuation.
Comparative Context
| Intake ranges studied | Source/form | Populations studied | Absorption/metabolic impact | Limitations |
|---|---|---|---|---|
| 5 – 25 mg/day | CBD gummies (gelatin) | Healthy adults (18–45 yr) | Low bioavailability; enhanced with dietary fat | Small sample sizes; short‑term follow‑up |
| 300 – 600 mg/day | Full‑spectrum oil tincture | Patients with chronic anxiety | Higher plasma peaks; first‑pass metabolism | Potential THC trace; variable purity |
| 50 – 100 mg/day | Nano‑emulsion capsules | Older adults (65+ yr) with osteoarthritis | Improved lymphatic transport; ~30 % bioavailability | Manufacturing consistency not proven |
| 100 – 150 mg/day + THC ≤ 0.3 % (Broad‑spectrum) | Adults with neuropathic pain | Mixed gender; comorbid hypertension | Moderate absorption; minimal psychoactivity | Limited long‑term safety data |
Population Trade‑offs
H3 - Young Healthy Adults
Low‑dose gummies provide a convenient entry point with minimal side‑effect risk, but the limited bioavailability may require higher consumption for measurable effects, potentially increasing gastrointestinal complaints.
H3 - Middle‑Age Patients with Anxiety
Full‑spectrum oil delivers higher systemic CBD levels, which can be advantageous for anxiety management. However, trace THC may cause psychoactive sensations in sensitive individuals, and drug‑interaction risk rises due to CYP enzyme competition.
H3 - Older Adults and Bone Health
Nano‑emulsion capsules enhance absorption, supporting anti‑inflammatory goals in osteoarthritis. Yet, older adults often take polypharmacy regimens; clinicians should monitor for additive sedative effects and hepatic enzyme changes.
Safety
Commonly Reported Side Effects
- Dry Mouth (Xerostomia): Occurs in 2 %–9 % of users, likely due to CB1 modulation of salivary glands.
- Diarrhea or Gastrointestinal Discomfort: Higher incidence with oil tinctures taken on an empty stomach.
- Drowsiness or Fatigue: More frequent at doses ≥300 mg/day; may impair driving or operating machinery.
- Changes in Appetite: Mild increase or decrease, dependent on individual endocannabinoid tone.
Populations Requiring Caution
- Pregnant or Breastfeeding Women: Current guidelines from the American College of Obstetricians and Gynecologists advise against CBD use due to insufficient safety data.
- Individuals on Anticoagulants (e.g., warfarin): CBD can inhibit CYP2C19, potentially enhancing anticoagulant effect; monitoring INR is recommended.
- Patients with Liver Disease: Elevated liver enzymes observed at high doses; clinicians should assess baseline hepatic function.
Drug‑Interaction Potential
Because CBD shares metabolic pathways with many prescription drugs, concurrent use may increase plasma concentrations of medications such as clobazam, carbamazepine, and certain antidepressants. A 2023 clinical trial involving GW Pharmaceuticals' Epidiolex® (purified CBD) demonstrated a 30 %–50 % rise in plasma levels of concomitant antiepileptic drugs, underscoring the importance of therapeutic drug monitoring.
Guidance for Professional Oversight
Given the variability in product quality, dosing, and individual metabolism, consultation with a healthcare provider-preferably one knowledgeable about cannabinoid pharmacology-is advisable before initiating regular cannabis oil consumption, especially for individuals with chronic conditions or complex medication regimens.
Frequently Asked Questions
Can cannabis oil cause fatigue?
Yes, fatigue or drowsiness is among the more commonly reported side effects, particularly at daily doses of 300 mg or higher. The effect is dose‑dependent and may be amplified when combined with other sedatives.
Is it safe for pregnant women?
Current evidence is insufficient to confirm safety, and most professional societies recommend avoiding cannabis oil throughout pregnancy and lactation due to potential fetal exposure to cannabinoids.
How does it interact with common medications?
CBD inhibits several cytochrome P450 enzymes, which can increase serum concentrations of drugs metabolized by CYP3A4 and CYP2C19. This interaction may alter the efficacy or toxicity of anticoagulants, antiepileptics, and certain antidepressants.
What is the typical onset time for side effects?
Acute side effects such as dry mouth or mild gastrointestinal upset often appear within 30 minutes to 2 hours after ingestion, aligning with peak plasma levels. Longer‑term changes, like liver enzyme elevations, may develop after weeks of high‑dose use.
Can long‑term use lead to tolerance?
Some studies suggest a modest reduction in subjective effects after continuous daily dosing for several weeks, indicating possible pharmacodynamic tolerance. Rotating dosing schedules or periodic drug holidays are strategies some clinicians discuss, though robust evidence is lacking.
Disclaimer
This content is for informational purposes only. Always consult a healthcare professional before starting any supplement.